SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

YIELD10 Bioscience, Inc. 
 MA
  SEC # 1121702


        
    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

256  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
4/1/24New Filing!  10-K1Able of Contents
5/4/23424B51About This Prospectus
1About This Prospectus Supplement
1About Yield10 Bioscience, Inc
4/19/24New Filing!  PRE 14A1Board of Directors and Its Committees, The
4/1/24New Filing!  10-K1Business
8/11/23424B41Capitalization
4/19/24New Filing!  PRE 14A1Certain Relationships and Related Person Transactions
4/1/24New Filing!  10-K1Certain Relationships and Related Transactions, and Director Independence
1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
8/14/2310-Q1Condensed Consolidated Balance Sheets at June 30, 2023 and December 31, 2022
5/12/2310-Q1Condensed Consolidated Balance Sheets at March 31, 2023 and December 31, 2022
11/14/2310-Q1Condensed Consolidated Balance Sheets at September 30, 2023 and December 31, 2022
1Condensed Consolidated Financial Statements (unaudited)
1Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022
8/14/2310-Q1Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2023 and 2022
5/12/2310-Q1Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022
11/14/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022
8/14/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended June 30, 2023 and 2022
5/12/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2023 and 2022
11/14/2310-Q1Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2023 and 2022
8/14/2310-Q1Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2023 and 2022
5/12/2310-Q1Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022
11/14/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three and nine months ended September 30, 2023 and 2022
8/14/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three and six months ended June 30, 2023 and 2022
5/12/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2023 and 2022
4/1/24New Filing!  10-K1Consolidated Balance Sheets as of December 31, 2023 and 2022
1Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Operations for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Stockholders' Equity (Deficit) for the Years Ended December 31, 2023 and 2022
1Controls and Procedures
4/19/24New Filing!  PRE 14A1Corporate Governance and Board Matters
5/4/23424B51Corporate Information
4/1/24New Filing!  10-K1Cybersecurity
11/14/2310-Q1Defaults Upon Senior Securities
8/11/23424B41Description of Capital Stock
7/18/23424B31Description of Our Capital Stock
8/11/23424B41Description of Securities We Are Offering
5/4/23424B51Description of Subscription Rights
1Description of the Securities We Are Offering
1Description of Units
1Description of Warrants
8/11/23424B41Dilution
4/19/24New Filing!  PRE 14A1Director Compensation
1Directors and Executive Officers
4/1/24New Filing!  10-K1Directors, Executive Officers and Corporate Governance
7/18/23424B31Disclosure of Commission Position on Indemnification for Securities Act Liabilities
4/1/24New Filing!  10-K1Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
8/11/23424B41Dividend Information
7/18/23424B31Dividend Policy
4/19/24New Filing!  PRE 14A1Executive Compensation
11/14/2310-Q1Exhibits
4/1/24New Filing!  10-K1Exhibits and Financial Statement Schedules
8/11/23424B41Experts
4/1/24New Filing!  10-K1Financial Statements and Supplementary Data
1Form 10-K Summary
4/19/24New Filing!  PRE 14A1Important Information About the Annual Meeting and Voting
7/18/23424B31Incorporation of Certain Documents by Reference
5/4/23424B51Incorporation of Certain Information by Reference
8/11/23424B41Incorporation of Documents by Reference
4/19/24New Filing!  PRE 14A1Independent Registered Public Accountants
4/1/24New Filing!  10-K1Index to Consolidated Financial Statements
1Information about Our Directors and Officers
1Item 1
1Item 10
1Item 11
1Item 12
1Item 13
1Item 14
1Item 15
1Item 16
1Item 1A
1Item 1B
1Item 1C
1Item 2
1Item 3
1Item 4
1Item 5
1Item 6
1Item 7
1Item 7A
1Item 8
1Item 9
1Item 9A
1Item 9B
1Item 9C
8/11/23424B41Legal Matters
4/1/24New Filing!  10-K1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
7/18/23424B31Market for Our Common Stock
4/1/24New Filing!  10-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
8/11/23424B41Material U.S. Federal Income Tax Consequences to Holders of Common Stock and Warrants
4/1/24New Filing!  10-K1Mine Safety Disclosures
1Notes to Consolidated Financial Statements
11/14/2310-Q1Notes to the Condensed Consolidated Financial Statements
8/11/23424B41Offering, The
4/1/24New Filing!  10-K1Other Information
4/19/24New Filing!  PRE 14A1Other Matters
4/1/24New Filing!  10-K1Part I
11/14/2310-Q1Part I. Financial Information
4/1/24New Filing!  10-K1Part Ii
11/14/2310-Q1Part II. Other Information
4/1/24New Filing!  10-K1Part Iii
1Part Iv
4/19/24New Filing!  PRE 14A1Pay Versus Performance
8/11/23424B41Plan of Distribution
8/2/23S-1/A1Power of Attorney (included in the signature pages to the registration statement)
4/1/24New Filing!  10-K1Principal Accounting Fees and Services
5/4/23424B51Private Placement Transaction
4/1/24New Filing!  10-K1Properties
4/19/24New Filing!  PRE 14A1Proposal No. 1 ELECTION OF DIRECTORS
1Proposal No. 2 APPROVAL TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK
1Proposal No. 3 APPROVAL TO ADJOURN ANNUAL MEETING TO A LATER DATE TO PERMIT FURTHER SOLICITATION
1Proposal No. 4 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
1Proposal No. 5 ADVISORY VOTE ON COMPENSATION OF NAMED EXECUTIVE OFFICERS
1Proposal No. 6 ADVISORY VOTE ON FREQUENCY OF FUTURE ADVISORY VOTES ON COMPENSATION OF NAMED EXECUTIVE OFFICERS
1Proposal No. 7 APPROVAL OF ISSUANCE OF SHARES UPON EXERCISE OF WARRANTS
1Proposal No. 8 APPROVAL OF AN AMENDMENT TO THE COMPANY'S 2018 STOCK OPTION AND INCENTIVE PLAN...
8/11/23424B41Prospectus Summary
5/4/23424B51Prospectus Supplement Summary
4/1/24New Filing!  10-K1Quantitative and Qualitative Disclosures About Market Risk
4/19/24New Filing!  PRE 14A1Report of the Audit Committee
4/1/24New Filing!  10-K1Reserved
1Risk Factors
5/4/23424B51S-1
1S-11
1S-12
1S-13
1S-15
1S-17
1S-20
1S-21
1S-3
1S-6
1S-8
4/19/24New Filing!  PRE 14A1Securities Authorized for Issuance Under Equity Compensation Plans
1Security Ownership of Certain Beneficial Owners and Management
4/1/24New Filing!  10-K1Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
7/18/23424B31Selling Security Holders
4/1/24New Filing!  10-K1Signatures
8/11/23424B41Special Note Regarding Forward-Looking Statements
4/19/24New Filing!  PRE 14A1Stockholder Proposals and Nominations for Director
4/1/24New Filing!  10-K1Table of Contents
4/19/24New Filing!  PRE 14A1The Board of Directors and Its Committees
8/11/23424B41The Offering
7/13/23S-11Underwriting
11/14/2310-Q1Unregistered Sales of Equity Securities and Use of Proceeds
4/1/24New Filing!  10-K1Unresolved Staff Comments
8/11/23424B41Use of Proceeds
5/4/23424B51Where You Can Find Additional Information
8/11/23424B41Where You Can Find More Information
11/14/2310-Q11A

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:44:56.2pm ET